th biosimilars congress · 2019. 9. 27. · biosimilars approval to biogenerics in clinical...

Biosimilars CongressApril 01-02, 2020

London, UK

13th European

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAMDAY 1

Wednesday 01st, April

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Current Challenges in Developing Biosimilars

Talks On: Analytical Strategies for Biosimilars and Intellectual Property Rights

Biopharmaceuticals development Biosimilars multimodal techniques

Quality by Design for Biologics and Biosimilars Biosimilars bioanalytical methods

Implimentation of the BPCI Act Bioassay for comparability and potency testing

Advertising, promotion and labelling essentials

Biosimilars LC/MS analysis for discovery, preclinical and clinical programs

Unique considerations for biologics Biosimilars GMP protein analysis

Comparability for biologics Biosimilars electrophoresis

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK


14:00-16:00 Talks On: Biological Medicine and Emerging Biosimilars in Therapeutics

Talks On: Innovative Clinical Approach in Bio-similars and Biosimilars Research Pipeline

Advances in biological products Biosimilars clinical trials

Biological drugs Clinical PK/PD studies

Generic biological drugs Toxicological studies

Biologics in cancer Risk management and quality affairs

Biologics in autoimmune disease Future of next generation biosimilars


MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Pharmaceutical Sciences

Workshop

Visit: https://biosimilars-biologics.pharmaceuticalconferences.com/europe/

SCIENTIFIC PROGRAMDAY 2

Thursday 02nd, April

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES



10:50-12:50 Talks On: Regulatory Updates on Biosimilars &Biosimilars Development in Markets

Talks On: Biosimilars Approval to Biogenerics in Clinical Practice

Licensing of biosimilars Biotechnologic drug

BLA filing for biosimilars Monoclonal antibody

Regulatory prospects of BRIC countries Fusion protein

Biosimilars USA Biologic drug

Biosimilars Europe Anti–tumor necrosis factor

12:50-13:35 LUNCH BREAK


13:35-15:55 Talks On: Biopharmaceutical Informatics &Consequences of Brexit on Biosimilars

Talks On: BCS and IVIVC Based Biowaivers & Globaliza-tion of Biosimilars

Applications of computation in biologic drug development BCS biowaivers

Physics-based molecular modelling Preclinical and clinical testing for oral drug delivery

Protein sequence-structural contexts and degradation reaction mechanisms

Waiver for In vivo bioavailability or bioequivalence

Brexit- Pros and Cons to European pharma market Global impact of biosimilars over generics

Post Brexit changes in biosimilars regulation in UK Economic aspect towards biosimilars

Fate of biosimilars clinical trials in UK Biosimilars in global market


MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop


Organizing Committee Members


Andras Guttman Sciex Separations, USA

Cecil NickPAREXEL, UK

Fiona M GreerSGS Life Sciences,

Switzerland

Parastoo AzadiComplex Carbohydrtae

Research Center - University

of Georgia, USA

David EbsworthVifor Pharma Ltd,

Switzerland

Francois-Xavier FrapaiseBiosimilars Consultant, France

Dominic SeitzSimon-Kucher & Partners,

Germany

Kamali ChanceBioSciencesCorp, USA

Christoph Volpers Michalski Hüttermann &

Partners, Germany

Andras Guttman Sciex Separations, USA

Fiona M Greer SGS Life Sciences, Switzerland

Francois-Xavier Frapaise Biosimilars Consultant, France

Parastoo Azadi Complex Carbohydrtae Research Center - University of Georgia, USA

Cecil Nick PAREXEL International, UK

Dominic Seitz Simon-Kucher & Partners, Germany

David Ebsworth Vifor Pharma Ltd, Switzerland

Sakae Tsuda National Institute of Advanced Industrial Science and Technology, Japan

Emile Van Corven Bioceros, Netherlands

Thomas Kofoed Alphalyse A/S, Denmark

R Helena Bustos-Cruz Universidad de La Sabana, Colombia

M. Carme Parés Santilari European Bio Immune(G)ene Medicine Association, France

Kurt R Karst Hyman, Phelps & McNamara, P C, USA

Kamali Chance BioSciencesCorp, USA

Roberto Valenti DLA Piper, Italy

Theo Christie National Institute for Health Research, UK

Archana Shubhakar Ludger Ltd, UK

Fatemeh Torkashvand Pasteur Institute of Iran, Iran

Roberta Bursi InsilicoTRIALS, Italy

Victor Tsetlin Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Russia

Padma Priya Anand Baskaran ReeLabs Pvt. Ltd., India

Eraldo Martins Guerra Filho Recife Center for Advanced Studies and Systems, Brazil

Oleksandr Kukharchuk ReeLabs Pvt. Ltd., India

Tsachi Shaked Elcam Drug Delivery Devices, Israel

Menachem Zucker E3D Elcam Drug Delivery Devices, Israel

Mohammed H Alwan Al Nahrain University, Iraq

PAST AFFILIATESPA

ST A

FFIL

IATE

S


Logean Q Al Karam Al Nahrain University, Iraq

Thomas Zahel Exputec GmbH, Austria

Yazan Shaban Hikma Pharmaceuticals, Jordan

Cecil Nick PAREXEL International, UK

Pavel Vítámvás Crop Research Institute, Czech Republic

Anna Shaliutina-Kolesova University of South Bohemia Ceské Budejovice, Czech Republic

Hamdi Uysal Ankara University, Turkey

Hana Ujcikova Institute of Physiology-Czech Academy of Sciences, Czech Republic

Peter Nilsson KTH-Royal Institute of Technology, Sweden

Peter Nilsson KTH-Royal Institute of Technology, Sweden

Sara Motta National Research Council, Italy

Patrícia Sampaio Tavares Veras Gonçalo Moniz Research Center- FIOCRUZ, Brazil

Patricia Renard University of Namur, Belgium

Alex Bayes Biomedical Research Institute Sant Pau, Spain

Mario Looso Max Planck Institute for Heart and Lung Research, Germany

Nadine Bongaerts Delft University of Technology, Netherlands

Lydia Siragusa Molecular Discovery Limited, UK

Thomas Schneider Philip Morris International, Switzerland Miguel Quintela-Fandino Spanish National Cancer Research Center, Spain

Andreu Soldevila Fabrega LeanBio, Spain

Alastair Waugh 3P Biopharmaceuticals, Spain

Carles Celma Lezcano Kymos Pharma Services, Spain

Tiziana Bonaldi European Institute of Oncology, Italy

Maria De Angelis University of Bari Aldo Moro, Italy

Jasmina N Jovanovic School of Pharmacy, UK

Huseyin Cimen Yeditepe University, Turkey

Stefanie Wienkoop University of Vienna, Austria

PAST AFFILIATESPA

ST A

FFIL

IATE

S


PAST AFFILIATESTamar Geiger Tel Aviv University, Israel

David Sheehan University Cork College, Ireland

Martine Cadene Centre de Biophysique Moléculaire, France

Claudine S Bonder University of South Australia, Australia

Fuad Fares University of Haifa, Israel

Eunjoo Kim Daegu Gyeongbuk Institue of Science and Technology (DGIST), South Korea

Jaime Jacqueline Jayapalan University of Malaya, Malaysia

Serhiy Souchelnytskyi Qatar University, Qatar

Vadim Govorun Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Russia

Akira Imaizumi Ajinomoto Co., Inc., Japan

Amilcar Perez-Riverol Sao Paulo State University, Brazil

Mohamad Khairi Zainol Universiti Malaysia Terengganu, Malaysia

Hasni Arsad Universiti Sains Malaysia, Malaysia

Carlos Eduardo A Souza

Cisne University, Brazil

Diogo Ribeiro Demartini Laboratorio de Proteinas Toxicas UNIPROTE-MS Centro de Biotecnologia – UFRGS , Brazil

Jamal Alruwaili Vice Dean Faculty of Applied Medical Sciences Northern Border University Arar, Saudi Arabia

Nadeem A. Kizilbash Northern Border University, Saudi Arabia

Chin Chiew Foan University of Nottingham, Malaysia

Jianshe Zhang Changsha University, China

John F Cipollo Center for Biologics Evaluation and Research-USFDA, USA

Wendy Sandoval Genentech, Inc. South San Francisco, USA

Xuequn Chen School of Medicine, Wayne State University, USA

Alan J. Tackett University of Arkansas for Medical Sciences, USAPA

ST A

FFIL

IATE

S


Euro Biosimilars Glimpses

London Attractions

Nat

iona

l Gal

lery

Tower Bridge

Bond

Stre

et

Elth

am P

alac

e

Lond

on Eye

Bucki

ngha

m P

alac

e

Cloc

k To

wer

lond

on sh

oppi

ng

westfield

Lond

on O

xfor

d St

reet

th biosimilars congress · 2019. 9. 27. · biosimilars approval to biogenerics in clinical...

Documents